|
|
Genome-wide analysis of developmental and sex-regulated gene expression profile. |
self-organizing map |
cgc4489_group_18
|
|
|
Transcripts that showed significantly decreased expression after animals grew in 500 uM glycine from hatch till 1-day post L4 adult, comparing to untreated animals. |
Differential expression was assessed using a nempirical Bayes moderated t-test within limmas linear model framework including the precision weights estimated by voom.Resulting p-values were corrected for multiple testing using the Benjamini-Hochberg false discovery rate. Curator applied threshold: fold change > 2, adjusted p-value < 0.01. |
WBPaper00056330:glycine_downregulated
|
|
|
Transcripts that showed significantly increased expression in pals-17(syb3980) comparing to in N2 animals at young adult stage. |
Differential expression analyses were performed using limma-voom in Galaxy, adj p <= 0.05, logFC > 2 |
WBPaper00065984:pals-17(syb3980)_upregulated
|
|
|
Transcripts that showed significantly increased expression in diploid N2 animals after exposure to 5 uM doxorubicin for 72 hours at 15C from L1 to L4 larve stage. |
DESeq2 R package (1.20.0), fold change > 2, and FDR < 0.05. |
WBPaper00066110:Doxorubicin_upregulated_diploid
|
|
|
Transcripts that showed significantly increased expression in tetraploid N2 comparing to diploid N2 animals at L4 larva stage. |
DESeq2 R package (1.20.0), fold change > 2, and FDR < 0.05. |
WBPaper00066110:tetraploid_vs_diploid_upregulated
|
|
|
Transcripts that showed significantly increased expression in animals with pan-neuronal expression of human amyloid beta (snb-1p-Amyloid-beta(1-42) + mtl-2p-GFP), comparing to in N2 animals. |
edgeR p-value < 0.01 and fold change > 4. |
WBPaper00061613:human-amyloid-beta_upregulated
|
|
|
Transcripts that showed significantly decreased expression in animals exposed to 400uM tamoxifen from L1 to L4 larva stage. |
DEseq2, fold change > 2 |
WBPaper00064505:tamoxifen_downregulated
|
|
|
Transcripts that showed more than 4 fold of expression in N2 comparing to in CB4856 animals. |
DESeq2, fold change > 4. |
WBPaper00053909:N2_vs_CB4856_upregulated
|
|
|
Transcripts that showed significantly increased expression in animals with pan-neuronal expression of both human amyloid beta (snb-1p-Amyloid-beta(1-42) + mtl-2p-GFP) and human alpha-Synuclein(A53T) (aex-3p-alpha-syn (A53T)), comparing to in N2 animals. |
edgeR p-value < 0.01 and fold change > 4. |
WBPaper00061613:human-amyloid-beta_alpha-Synuclein(A53T)_upregulated
|
|
|
Transcripts that showed significantly decreased expression in mrps-5(RNAi) animals comparing to animals injected with empty vector. |
Differential expression was assessed using a Partial least-squares discriminant analysis (PLS-DA) using mixomics setting a variable of importance (VIP) score of greater than 1 as significant. |
WBPaper00059328:mrps-5(RNAi)_downregulated_mRNA
|
|
|
Transcripts that showed significantly increased expression in strain AGD1289 with pan-neuronall expression of HSF-1, comparing to in N2 animals. |
DESeq2 v1.22.2, p-value < 0.05 and fold change > 2. |
WBPaper00062118:neural-HSF-1_upregulated
|
|
|
Transcripts that showed significantly altered expression in skn-1gf(lax188) comparing to in WT animals in ASI neuron. |
DESeq2, p-value < 0.05. |
WBPaper00066256:skn-1gf(lax188)_regulated
|
